Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PVAG in elderly patients with advanced stages Hodgkin's lymphoma
NCT00147875Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Mar 2004
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of gemcitabine in Hodgkin lymphoma (HL), sponsored by University of Cologne. Primary endpoints: Dose-limiting toxicities, Dose reductions and 2 more. Started Mar 2004; status: completed.
02
Drugs
gemcitabine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00147875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147875.